[Effect of Nocardia rubra cell wall skeleton against pleuritis carcinomatosa in adenocarcinoma of the lung]. 1983

N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani

Forty-one cases of adenocarcinoma of the lung with pleuritis carcinomatosa were randomly assigned to either chemotherapy alone or chemoimmunotherapy using Nocardia rubra cell wall skeleton as immunopotentiator. In 34 evaluable patients, the rates of volume decrease and the disappearance of tumor cells in pleural effusion were higher in chemoimmunotherapy group than in chemotherapy alone group, and median survival times from the beginning of treatment in chemotherapy alone and chemoimmunotherapy groups were 189 and 266 days, respectively. The survival times in patients with stage III and P.S. 0+1+2 were better than those in patients with stage IV and P.S. 3, respectively. Transient fever and mild elevation of GPT and GOT were tolerated without any treatment.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009615 Nocardia A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals. Micropolyspora
D010998 Pleurisy INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN. Pleuritis,Pleurisies,Pleuritides
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
April 1983, Nihon Geka Gakkai zasshi,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
January 1992, Cancer immunology, immunotherapy : CII,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
February 1979, Gan,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
April 1986, Cancer research,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
January 1981, Cancer treatment reports,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
August 1991, Cancer research,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
February 1982, Arerugi = [Allergy],
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
March 1980, European journal of cancer,
N Saijo, and K Eguchi, and K Tominaga, and T Shinkai, and E Shimizu, and M Shibuya, and Z Shimabukuro, and H Niitani
November 2022, Current issues in molecular biology,
Copied contents to your clipboard!